{"id":41557,"date":"2021-08-30T06:15:24","date_gmt":"2021-08-30T06:15:24","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=77967"},"modified":"2021-08-30T06:15:24","modified_gmt":"2021-08-30T06:15:24","slug":"kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test","status":"publish","type":"post","link":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/","title":{"rendered":"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test"},"content":{"rendered":"
\n
\n
\n

HONG KONG\u00a0and NAIROBI, Kenya, Aug. 30, 2021 \/PRNewswire\/ — PHASE Scientific announces that its\u00a0INDICAID\u2122 COVID-19 Rapid Antigen Test (INDICAID\u2122)<\/b>\u00a0has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic of Kenya on 17 August 2021. The authorization enables the test to be used in Kenya for the identification of COVID-19 cases, facilitating early isolation, diagnosis and treatment of patients.<\/p>\n

\"PHASE<\/div>\n

The INDICAID\u2122 COVID-19 Rapid Antigen Test is a lateral flow immunoassay designed for qualitative detection of SARS-CoV-2 antigens.\u00a0Unlike other testing methods that use nasopharyngeal swab specimens, INDICAID\u2122 uses nasal swab specimens to provide fast results within 20 minutes without need of any special equipment or facilities.<\/p>\n

INDICAID\u2122 has been validated in the world’s largest clinical trial for a product of its kind, results from which have been published in Microbiology Spectrum<\/i><\/b> on 4 August 2021. In this Dual-Track testing trial, 22,994 asymptomatic subjects were tested using both INDICAID\u2122 and a confirmatory RT-PCR test at COVID-19 community testing centers in Hong Kong. Results show that INDICAID\u2122 has excellent sensitivity and specificity and is effective for fast population screening.<\/p>\n

“The authorization of INDICAID\u2122\u00a0from various countries indicates our technology and quality are well-recognized globally,” says Dr.\u00a0Ricky Chiu Yin-to, Founder and CEO of PHASE Scientific. “Thanks to INDICAID’s high sensitivity, not only can the product help detect symptomatic positive cases, it can also be used for screening in asymptomatic populations.” Dr. Chiu has also mentioned that Kenya is the first market in Africa the Company enters, and that it will continue expanding to other African countries to help combat COVID-19.<\/p>\n

INDICAID\u2122 COVID-19 Rapid Antigen Test has received\u00a0Emergency Use Authorization from the US Food & Drug Administration (FDA) and the European CE Mark. The kit has been widely adopted in COVID-19 testing centers, hospitals, government and private corporations, supermarkets, hotels and schools in Hong Kong and overseas. INDICAID\u2122 is currently available in 33 countries, and is the best-selling rapid test kit in Hong Kong.<\/p>\n

About Phase Scientific International LTD:\u00a0<\/b>PHASE Scientific is a high-growth biotech company founded by a team of bioengineers from\u00a0UCLA. The organization is focused on building tools that empower people by giving them better information about their health. Headquartered in\u00a0Hong Kong, its footprint includes research and development, manufacturing and distribution in\u00a0Hong Kong, mainland\u00a0China\u00a0and\u00a0Southern California. For more information:\u00a0https:\/\/phasescientific.com\/<\/a>.<\/p>\n

Logo – https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HONG KONG\u00a0and NAIROBI, Kenya, Aug. 30, 2021 \/PRNewswire\/ \u2014 PHASE Scientific announces that its\u00a0INDICAID\u2122 COVID-19 Rapid Antigen Test (INDICAID\u2122)\u00a0has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic of Kenya on 17 August 2021. The authorization enables the test to be used in Kenya for the identification of COVID-19 cases, facilitating [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[],"yoast_head":"\nKenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test - Daily South Africa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test - Daily South Africa\" \/>\n<meta property=\"og:description\" content=\"HONG KONG\u00a0and NAIROBI, Kenya, Aug. 30, 2021 \/PRNewswire\/ \u2014 PHASE Scientific announces that its\u00a0INDICAID\u2122 COVID-19 Rapid Antigen Test (INDICAID\u2122)\u00a0has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic of Kenya on 17 August 2021. The authorization enables the test to be used in Kenya for the identification of COVID-19 cases, facilitating [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/\" \/>\n<meta property=\"og:site_name\" content=\"Daily South Africa\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-30T06:15:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg\" \/>\n<meta name=\"author\" content=\"dsadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"dsadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/\"},\"author\":{\"name\":\"dsadmin\",\"@id\":\"https:\/\/dailysouthafrica.com\/#\/schema\/person\/2a33aa070be656c537b2ec7a02fba740\"},\"headline\":\"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test\",\"datePublished\":\"2021-08-30T06:15:24+00:00\",\"dateModified\":\"2021-08-30T06:15:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/\"},\"wordCount\":409,\"publisher\":{\"@id\":\"https:\/\/dailysouthafrica.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/\",\"url\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/\",\"name\":\"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test - Daily South Africa\",\"isPartOf\":{\"@id\":\"https:\/\/dailysouthafrica.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg\",\"datePublished\":\"2021-08-30T06:15:24+00:00\",\"dateModified\":\"2021-08-30T06:15:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#primaryimage\",\"url\":\"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg\",\"contentUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dailysouthafrica.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dailysouthafrica.com\/#website\",\"url\":\"https:\/\/dailysouthafrica.com\/\",\"name\":\"Daily South Africa\",\"description\":\"Latest News From South Africa\",\"publisher\":{\"@id\":\"https:\/\/dailysouthafrica.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dailysouthafrica.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/dailysouthafrica.com\/#organization\",\"name\":\"Daily South Africa\",\"url\":\"https:\/\/dailysouthafrica.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dailysouthafrica.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2022\/07\/cropped-8e3924cf-36ef-47fa-b41a-9c8c4f299cda_200x200-1-1.png\",\"contentUrl\":\"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2022\/07\/cropped-8e3924cf-36ef-47fa-b41a-9c8c4f299cda_200x200-1-1.png\",\"width\":200,\"height\":93,\"caption\":\"Daily South Africa\"},\"image\":{\"@id\":\"https:\/\/dailysouthafrica.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/dailysouthafrica.com\/#\/schema\/person\/2a33aa070be656c537b2ec7a02fba740\",\"name\":\"dsadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dailysouthafrica.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"dsadmin\"},\"url\":\"https:\/\/dailysouthafrica.com\/author\/ds-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test - Daily South Africa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/","og_locale":"en_US","og_type":"article","og_title":"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test - Daily South Africa","og_description":"HONG KONG\u00a0and NAIROBI, Kenya, Aug. 30, 2021 \/PRNewswire\/ \u2014 PHASE Scientific announces that its\u00a0INDICAID\u2122 COVID-19 Rapid Antigen Test (INDICAID\u2122)\u00a0has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic of Kenya on 17 August 2021. The authorization enables the test to be used in Kenya for the identification of COVID-19 cases, facilitating [\u2026]","og_url":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/","og_site_name":"Daily South Africa","article_published_time":"2021-08-30T06:15:24+00:00","og_image":[{"url":"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg"}],"author":"dsadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"dsadmin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#article","isPartOf":{"@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/"},"author":{"name":"dsadmin","@id":"https:\/\/dailysouthafrica.com\/#\/schema\/person\/2a33aa070be656c537b2ec7a02fba740"},"headline":"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test","datePublished":"2021-08-30T06:15:24+00:00","dateModified":"2021-08-30T06:15:24+00:00","mainEntityOfPage":{"@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/"},"wordCount":409,"publisher":{"@id":"https:\/\/dailysouthafrica.com\/#organization"},"image":{"@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#primaryimage"},"thumbnailUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/","url":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/","name":"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test - Daily South Africa","isPartOf":{"@id":"https:\/\/dailysouthafrica.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#primaryimage"},"image":{"@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#primaryimage"},"thumbnailUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg","datePublished":"2021-08-30T06:15:24+00:00","dateModified":"2021-08-30T06:15:24+00:00","breadcrumb":{"@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#primaryimage","url":"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg","contentUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/MRVGpAUCgapdvJh1b0W4Uky5aws8FxQMvUqEBKkWPYu4pBvJR8wlRbMIv4TNJkR-OgFkaRdH0iVo58On66NO4ajkUnjzlpuZdQfmEjoWhwWmU7pwuXoGTTTtLMh4=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1214883\/PHASE_Scientific_Company_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/dailysouthafrica.com\/kenya-grants-emergency-use-authorization-for-the-indicaidtm-covid-19-rapid-antigen-test\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailysouthafrica.com\/"},{"@type":"ListItem","position":2,"name":"Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test"}]},{"@type":"WebSite","@id":"https:\/\/dailysouthafrica.com\/#website","url":"https:\/\/dailysouthafrica.com\/","name":"Daily South Africa","description":"Latest News From South Africa","publisher":{"@id":"https:\/\/dailysouthafrica.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailysouthafrica.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/dailysouthafrica.com\/#organization","name":"Daily South Africa","url":"https:\/\/dailysouthafrica.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dailysouthafrica.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2022\/07\/cropped-8e3924cf-36ef-47fa-b41a-9c8c4f299cda_200x200-1-1.png","contentUrl":"https:\/\/dailysouthafrica.com\/wp-content\/uploads\/2022\/07\/cropped-8e3924cf-36ef-47fa-b41a-9c8c4f299cda_200x200-1-1.png","width":200,"height":93,"caption":"Daily South Africa"},"image":{"@id":"https:\/\/dailysouthafrica.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/dailysouthafrica.com\/#\/schema\/person\/2a33aa070be656c537b2ec7a02fba740","name":"dsadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dailysouthafrica.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"dsadmin"},"url":"https:\/\/dailysouthafrica.com\/author\/ds-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/posts\/41557"}],"collection":[{"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/comments?post=41557"}],"version-history":[{"count":0,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/posts\/41557\/revisions"}],"wp:attachment":[{"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/media?parent=41557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/categories?post=41557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailysouthafrica.com\/wp-json\/wp\/v2\/tags?post=41557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}